Freenome Raises $254M to Accelerate Early Cancer Detection Platform
Freenome, a leader in blood-based early cancer detection, has raised $254M, fueled by its innovative multiomics platform
Source: hitconsultant.net
Stay updated with breaking news from Freenome Raises. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Freenome, a leader in blood-based early cancer detection, has raised $254M, fueled by its innovative multiomics platform